🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

REVIEW Trends in Immunology Liquid–liquid phase separation in innate immunity cell.com/trends/immunol…

Those in RT field, please do register.

I'm thrilled to share our latest study in Nature Communications. We discovered a new mechanism of chemotherapy resistance in BRCA-deficient tumors and a new way to fight it! Thank you all for your contribution!! nature.com/articles/s4146…

A few well known names of great scientists here including my brilliant former colleagues, Sara Przetocka and Ewa Gogola. Look forward to read this paper in details. Well done everyone!

A throwback to #ESTRO24. It was a great pleasure to meet many inspiring people, listen to excellent talks, and present my work in front of international RadOnc community. An opportunity to explore green and artsy Glasgow was a bonus💚

It doesn’t happen often that your paper ranks among the top 10 cited articles in years 2022-2023. A little victory that I would like to share 💙 #TopCitedArticle

Britt Adamson Sharon B. Cantor Karlene Cimprich @IcrLordLab ZZZ @NimaMLab andre nussenzweig lab Lee Zou Boyi Gan, PhD Please repost to help spread the word - thank you🙏 Karras Lab Kara Bernstein Deriano Lab Garnett Lab Michael Huen Ron Jachimowicz @leunglaboratory Schellenberg Lab stuckilab Marek Adamowicz @cjcarnie Alison Harrod Arne N. Kousholt Domenic Pilger Radoslaw Szmyd Vithursha Thanendran Claudio Lademann

If you want to hear more about how the most accurate DSB repair pathway, named homologous recombination, restricts interferon signalling and drives immediate cell death following lethal genomic damage, please join me on September 11.

Our paper on a new approach to precision radiotherapy -- “Genotype-Directed Synthetic Cytotoxicity of ATR Inhibition with Radiotherapy” led by Victor Ng and Sonali Sinha is out in Clinical Cancer Research #radonc #radbio (1/N) aacrjournals.org/clincancerres/…

Let the fun begin! #DNArepair24

It’s a privilege to be a part of the organising committee of #LuminesceAlliance2024 Conference in Sydney. It’s gonna be two days packed with excellent science. Look forward to it!

For those who would like to know more about my research, here’s a beautiful video/story that describes a game-changing radiation therapy technique called SABR (a focus of my research), which offers hope to people living with lung cancer, like Derek Peffer. targetingcancer.com.au/dereks-story/

1/Delighted to announce the newest paper from our lab, “Homologous recombination promotes non-immunogenic mitotic cell death upon DNA damage”, is out today in Nature Cell Biology, nature.com/articles/s4155….

It’s finally out! nature.com/articles/s4155… Briefly, we have demonstrated that cell cycle dependent DNA/DSB repair pathways guide death outcomes following lethal genomic damage (like SBRT/SABR). HR was the driver of non-immunogenic mitotic death at first attempted division.

Hard work has paid off and my research findings have been published today in Nature Cell Biology 🧬

Thank you, Tony Cesare and Harriet Gee for your support and supervision along the way. They were invaluable!

Hi everyone, As of today, I have decided to stop using Twitter/X and fully relocate to BlueSky platform. If you would like to stay in touch, please follow my profile. I hope to see you there! bsky.app/profile/szmyd-…

Thank Sophie for a wonderful talk. This week, Dr. Tony Cesare Tony Cesare will speak on Social DNAing - exciting story on intricating link among, HR, mitosis and innate immune response. Please sign up at cancer.columbia.edu/research/progr…

On World Cancer Day, we acknowledge the extraordinary work of Prof Tony Cesare and Dr Radoslaw Szmyd who recently, not only made a huge breakthrough about the way radiotherapy kills cells, but whose work has now moved into the Top 5% of most read research papers across the world.

Don’t miss out on Tony’s talk during which he will dive into details of recently published research project that I had a pleasure to lead.